Exploring molecular interactions of potential inhibitors against the spleen tyrosine kinase implicated in autoimmune disorders via virtual screening and molecular dynamics simulations

References

• A. Richard-Eaglin and B.A. Smallheer, Immunosuppressive/autoimmune disorders, Nurs. Clin. North Am. 53 (2018), pp. 319–334. doi:10.1016/j.cnur.2018.04.002.
   PubMed Web of Science ®Google Scholar
• Y. Shao, S. Zhang, Y. Zhang, and Z. Liu, Recent advance of spleen tyrosine kinase in diseases and drugs, Int. Immunopharmacol. 90 (2021), pp. 107168. doi:10.1016/j.intimp.2020.107168.
   PubMed Web of Science ®Google Scholar
• G. Ku and B. Malissen, Chromosomal location of the Syk and ZAP-70 tyrosine kinase genes in mice and humans, Immunogenetics 40 (1994), pp. 300–302. doi:10.1007/BF00189976.
   PubMed Web of Science ®Google Scholar
• P.A. Goodman, C.M. Wood, A. Vassilev, C. Mao, and F.M. Uckun, Spleen tyrosine kinase (Syk) deficiency in childhood pro-B cell acute lymphoblastic leukemia, Oncogene 20 (2001), pp. 3969–3978. doi:10.1038/sj.onc.1204515.
   PubMed Web of Science ®Google Scholar
• K. Sada, T. Takano, S. Yanagi, and H. Yamamura, Structure and function of Syk protein-tyrosine kinase, J. Biochem. 130 (2001), pp. 177–186. doi:10.1093/oxfordjournals.jbchem.a002970.
   PubMed Web of Science ®Google Scholar
• S.P. McAdoo and F.W.K. Tam, Spleen tyrosine kinase: A novel target in autoimmunity, in Immunosuppression - Role in Health and Diseases, S. Kapur, ed., InTech, London, 2012, pp. 41–56.
   Google Scholar
• S. Ben Mkaddem, M. Benhamou, and R.C. Monteiro, Understanding Fc receptor involvement in inflammatory diseases: From mechanisms to new therapeutic tools, Front. Immunol. 10 (2019), pp. 811. doi:10.3389/fimmu.2019.00811.
   PubMed Web of Science ®Google Scholar
• A. Mócsai, J. Ruland, and V.L.J. Tybulewicz, The SYK tyrosine kinase: A crucial player in diverse biological functions, Nat. Rev. Immunol. 10 (2010), pp. 387–402. doi:10.1038/nri2765.
   PubMed Web of Science ®Google Scholar
• T. Takai, Roles of Fc receptors in autoimmunity, Nat. Rev. Immunol. 2 (2002), pp. 580–592. doi:10.1038/nri856.
   PubMed Web of Science ®Google Scholar
• F. Nimmerjahn, Activating and inhibitory FcγRs in autoimmune disorders, Springer Semin. Immunopathol. 28 (2006), pp. 305–319. doi:10.1007/s00281-006-0052-1.
   PubMed Web of Science ®Google Scholar
• S. Dubey, P. Prabitha, S. Bhardwaj, and E. Singh, A study of pyrazolo-benzimidazole derivatives as spleen tyrosine kinase inhibitors: An in-silico approach, Struct. Chem. 30 (2019), pp. 263–272. doi:10.1007/s11224-018-1189-y.
   Web of Science ®Google Scholar
• M.-C. Tung, K.-C. Tsai, K.-M. Fung, M.-J. Don, and T.-S. Tseng, Characterizing the structure–Activity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase, RSC Adv. 11 (2021), pp. 2453–2461. doi:10.1039/D0RA08769F.
   PubMed Web of Science ®Google Scholar
• S. Braselmann, V. Taylor, H. Zhao, S. Wang, C. Sylvain, M. Baluom, K. Qu, E. Herlaar, A. Lau, C. Young, B.R. Wong, S. Lovell, T. Sun, G. Park, A. Argade, S. Jurcevic, P. Pine, R. Singh, E.B. Grossbard, D.G. Payan, and E.S. Masuda, R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation, J. Pharmacol. Exp. Ther. 319 (2006), pp. 998–1008. doi:10.1124/jpet.106.109058.
   PubMed Web of Science ®Google Scholar
• A.G. Villaseñor, R. Kondru, H. Ho, S. Wang, E. Papp, D. Shaw, J.W. Barnett, M.F. Browner, and A. Kuglstatter, Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexes, Chem. Biol. Drug Des. 73 (2009), pp. 466–470. doi:10.1111/j.1747-0285.2009.00785.x.
   PubMed Web of Science ®Google Scholar
• A. Mullard, FDA approves first-in-class SYK inhibitor, Nat. Rev. Drug Discov. 17 (2018), pp. 385. doi:10.1038/nrd.2018.96.
   Web of Science ®Google Scholar
• S. Bartaula-Brevik, M.K. Lindstad Brattås, T.H.A. Tvedt, H. Reikvam, and Ø. Bruserud, Splenic tyrosine kinase (SYK) inhibitors and their possible use in acute myeloid leukemia, Expert Opin. Invest. Drugs 27 (2018), pp. 377–387. doi:10.1080/13543784.2018.1459562.
   PubMed Web of Science ®Google Scholar
• C. Mang, S. Jakupovic, S. Schunk, H.-D. Ambrosi, O. Schwarz, and J. Jakupovic, Natural products in combinatorial chemistry: An andrographolide-based library, J. Comb. Chem. 8 (2006), pp. 268–274. doi:10.1021/cc050143n.
   PubMedGoogle Scholar
• M.S. Mansueto, A. Reens, L. Rakhilina, A. Chi, B.-S. Pan, and J.R. Miller, A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism, J. Biol. Chem. 294 (2019), pp. 7658–7668. doi:10.1074/jbc.RA119.008045.
   PubMed Web of Science ®Google Scholar
• B. Webb and A. Sali, Comparative protein structure modeling using MODELLER, Curr. Protoc. Bioinf. 54 (2016), pp. 5.6.1–.5.6.37. doi:10.1002/cpbi.3.
   PubMedGoogle Scholar
• E.F. Pettersen, T.D. Goddard, C.C. Huang, G.S. Couch, D.M. Greenblatt, E.C. Meng, and T.E. Ferrin, UCSF Chimera-a visualization system for exploratory research and analysis, J. Comput. Chem. 25 (2004), pp. 1605–1612. doi:10.1002/jcc.20084.
   PubMed Web of Science ®Google Scholar
• D.A. Case, I.Y. Ben-Shalom, S.R. Brozell, D.S. Cerutti, I.T.E. Cheatham, V.W.D. Cruzeiro, T.A. Darden, R.E. Duke, D. Ghoreishi, M.K. Gilson, H. Gohlke, A.W. Goetz, D. Greene, R. Harris, N. Homeyer, Y. Huang, S. Izadi, A. Kovalenko, T. Kurtzman, T.S. Lee, S. LeGrand, P. Li, C. Lin, J. Liu, T. Luchko, R. Luo, D.J. Mermelstein, K.M. Merz, Y. Miao, G. Monard, C. Nguyen, H. Nguyen, I. Omelyan, A. Onufriev, F. Pan, R. Qi, D.R. Roe, A. Roitberg, C. Sagui, S. Schott-Verdugo, J. Shen, C.L. Simmerling, J. Smith, R. SalomonFerrer, J. Swails, R.C. Walker, J. Wang, H. Wei, R.M. Wolf, X. Wu, L. Xiao, D.M. York, and P.A. Kollman, Amber 2018. Univ. Calif. San Franc. (2018). software available at https://ambermd.org.
   Google Scholar
• J. Wang, W. Wang, P.A. Kollman, and D.A. Case, Automatic atom type and bond type perception in molecular mechanical calculations, J. Mol. Graph. Model. 25 (2006), pp. 247–260. doi:10.1016/j.jmgm.2005.12.005.
   PubMed Web of Science ®Google Scholar
• J.A. Maier, C. Martinez, K. Kasavajhala, L. Wickstrom, K.E. Hauser, and C. Simmerling, ff14SB: Improving the accuracy of protein side chain and backbone parameters from ff99SB, J. Chem. Theory Comput. 11 (2015), pp. 3696–3713. doi:10.1021/acs.jctc.5b00255.
   PubMed Web of Science ®Google Scholar
• J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, and D.A. Case, Development and testing of a general amber force field, J. Comput. Chem. 25 (2004), pp. 1157–1174. doi:10.1002/jcc.20035.
   PubMed Web of Science ®Google Scholar
• N. Homeyer, A.H.C. Horn, H. Lanig, and H. Sticht, AMBER force-field parameters for phosphorylated amino acids in different protonation states: Phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine, J. Mol. Model. 12 (2006), pp. 281–289. doi:10.1007/s00894-005-0028-4.
   PubMed Web of Science ®Google Scholar
• D.J. Price and C.L. Brooks, A modified TIP3P water potential for simulation with Ewald summation, J. Chem. Phys. 121 (2004), pp. 10096–10103. doi:10.1063/1.1808117.
   PubMed Web of Science ®Google Scholar
• G.M. Sastry, M. Adzhigirey, T. Day, R. Annabhimoju, and W. Sherman, Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments, J. Comput. Aided Mol. Des. 27 (2013), pp. 221–234. doi:10.1007/s10822-013-9644-8.
   PubMed Web of Science ®Google Scholar
• C.R. Søndergaard, M.H.M. Olsson, M. Rostkowski, and J.H. Jensen, Improved treatment of ligands and coupling effects in empirical calculation and rationalization of pKa values, J. Chem. Theory Comput. 7 (2011), pp. 2284–2295. doi:10.1021/ct200133y.
   PubMed Web of Science ®Google Scholar
• E. Harder, W. Damm, J. Maple, C. Wu, M. Reboul, J.Y. Xiang, L. Wang, D. Lupyan, M.K. Dahlgren, J.L. Knight, J.W. Kaus, D.S. Cerutti, G. Krilov, W.L. Jorgensen, R. Abel, and R.A. Friesner, OPLS3: A force field providing broad coverage of drug-like small molecules and proteins, J. Chem. Theory Comput. 12 (2016), pp. 281–296. doi:10.1021/acs.jctc.5b00864.
   PubMed Web of Science ®Google Scholar
• LigPrep. Schrödinger, LLC, New York, NY, 2023. software available at https://www.schrodinger.com/products/ligprep.
   Google Scholar
• J.R. Greenwood, D. Calkins, A.P. Sullivan, and J.C. Shelley, Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution, J. Comput. Aided Mol. Des. 24 (2010), pp. 591–604. doi:10.1007/s10822-010-9349-1.
   PubMed Web of Science ®Google Scholar
• R.A. Friesner, J.L. Banks, R.B. Murphy, T.A. Halgren, J.J. Klicic, D.T. Mainz, M.P. Repasky, E.H. Knoll, M. Shelley, J.K. Perry, D.E. Shaw, P. Francis, and P.S. Shenkin, Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem. 47 (2004), pp. 1739–1749. doi:10.1021/jm0306430.
   PubMed Web of Science ®Google Scholar
• T.A. Halgren, R.B. Murphy, R.A. Friesner, H.S. Beard, L.L. Frye, W.T. Pollard, and J.L. Banks, Glide: A new approach for rapid, accurate docking and scoring. 2. enrichment factors in database screening, J. Med. Chem. 47 (2004), pp. 1750–1759. doi:10.1021/jm030644s.
   PubMed Web of Science ®Google Scholar
• R.A. Friesner, R.B. Murphy, M.P. Repasky, L.L. Frye, J.R. Greenwood, T.A. Halgren, P.C. Sanschagrin, and D.T. Mainz, Extra precision Glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein−ligand complexes, J. Med. Chem. 49 (2006), pp. 6177–6196. doi:10.1021/jm051256o.
   PubMed Web of Science ®Google Scholar
• G. Xiong, Z. Wu, J. Yi, L. Fu, Z. Yang, C. Hsieh, M. Yin, X. Zeng, C. Wu, A. Lu, X. Chen, T. Hou, and D. Cao, ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties, Nucleic Acids Res. 49 (2021), pp. W5–W14. doi:10.1093/nar/gkab255.
   PubMed Web of Science ®Google Scholar
• D.R. Roe and T.E. Cheatham, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput. 9 (2013), pp. 3084–3095. doi:10.1021/ct400341p.
   PubMed Web of Science ®Google Scholar
• T. Darden, D. York, and L. Pedersen, Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems, J. Chem. Phys. 98 (1993), pp. 10089–10092. doi:10.1063/1.464397.
   Web of Science ®Google Scholar
• V. Kräutler, W.F. van Gunsteren, and P.H. Hünenberger, A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations, J. Comput. Chem. 22 (2001), pp. 501–508. doi:10.1002/1096-987X(20010415)22:5<501:AID-JCC1021>3.0.CO;2-V.
   Web of Science ®Google Scholar
• H.J.C. Berendsen, J.P.M. Postma, W.F. van Gunsteren, A. DiNola, and J.R. Haak, Molecular dynamics with coupling to an external bath, J. Chem. Phys. 81 (1984), pp. 3684–3690. doi:10.1063/1.448118.
   Web of Science ®Google Scholar
• R.W. Pastor, B.R. Brooks, and A. Szabo, An analysis of the accuracy of Langevin and molecular dynamics algorithms, Mol. Phys. 65 (1988), pp. 1409–1419. doi:10.1080/00268978800101881.
   Web of Science ®Google Scholar
• P.H. Hünenberger, A.E. Mark, and W.F. van Gunsteren, Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations, J. Mol. Biol. 252 (1995), pp. 492–503. doi:10.1006/jmbi.1995.0514.
   PubMed Web of Science ®Google Scholar
• B.J. Grant, A.P.C. Rodrigues, K.M. ElSawy, J.A. McCammon, and L.S.D. Caves, Bio3d: An R package for the comparative analysis of protein structures, Bioinformatics 22 (2006), pp. 2695–2696. doi:10.1093/bioinformatics/btl461.
   PubMed Web of Science ®Google Scholar
• T. Ichiye and M. Karplus, Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations, Proteins 11 (1991), pp. 205–217. doi:10.1002/prot.340110305.
   PubMed Web of Science ®Google Scholar
• A. Felline, M. Seeber, and F. Fanelli, webPSN v2.0: A webserver to infer fingerprints of structural communication in biomacromolecules, Nucleic Acids Res. 48 (2020), pp. W94–W103. doi:10.1093/nar/gkaa397.
   PubMed Web of Science ®Google Scholar
• W. Sun, The relationship between low-frequency motions and community structure of residue network in protein molecules, J. Comput. Biol. 25 (2018), pp. 103–113. doi:10.1089/cmb.2017.0171.
   PubMed Web of Science ®Google Scholar
• W. Humphrey, A. Dalke, and K. Schulten, VMD: Visual molecular dynamics, J. Mol. Graph. 14 (1996), pp. 33–38. doi:10.1016/0263-7855(96)00018-5.
   PubMed Web of Science ®Google Scholar
• B.R. Miller, T.D. McGee, J.M. Swails, N. Homeyer, H. Gohlke, and A.E. Roitberg, MMPBSA.py: An efficient program for end-state free energy calculations, J. Chem. Theory Comput. 8 (2012), pp. 3314–3321. doi:10.1021/ct300418h.
   PubMed Web of Science ®Google Scholar
• P.A. Kollman, I. Massova, C. Reyes, B. Kuhn, S. Huo, L. Chong, M. Lee, T. Lee, Y. Duan, W. Wang, O. Donini, P. Cieplak, J. Srinivasan, D.A. Case, and T.E. Cheatham, Calculating structures and free energies of complex molecules: Combining molecular mechanics and continuum models, Acc. Chem. Res. 33 (2000), pp. 889–897. doi:10.1021/ar000033j.
   PubMed Web of Science ®Google Scholar
• M.F. Sk, N.A. Jonniya, R. Roy, S. Poddar, and P. Kar, Computational investigation of structural dynamics of SARS-CoV-2 methyltransferase-stimulatory factor heterodimer nsp16/nsp10 bound to the cofactor SAM, Front. Mol. Biosci. 7 (2020), pp. 590165. doi:10.3389/fmolb.2020.590165.
   PubMed Web of Science ®Google Scholar
• M.F. Sk, R. Roy, N.A. Jonniya, S. Poddar, and P. Kar, Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations, J. Biomol. Struct. Dyn. 39 (2021), pp. 3649–3661. doi:10.1080/07391102.2020.1768149.
   PubMed Web of Science ®Google Scholar
• T.M. Creanza, G. Lamanna, P. Delre, M. Contino, N. Corriero, M. Saviano, G.F. Mangiatordi, and N. Ancona, DeLA-Drug: A deep learning algorithm for automated design of druglike analogues, J. Chem. Inf. Model. 62 (2022), pp. 1411–1424. doi:10.1021/acs.jcim.2c00205.
   PubMed Web of Science ®Google Scholar
• C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 23 (1997), pp. 3–25. doi:10.1016/S0169-409X(96)00423-1.
   Web of Science ®Google Scholar
• M.P. Gleeson, Generation of a set of simple, interpretable ADMET rules of thumb, J. Med. Chem. 51 (2008), pp. 817–834. doi:10.1021/jm701122q.
   PubMed Web of Science ®Google Scholar
• T.W. Johnson, K.R. Dress, and M. Edwards, Using the golden triangle to optimize clearance and oral absorption, Bioorg. Med. Chem. Lett. 19 (2009), pp. 5560–5564. doi:10.1016/j.bmcl.2009.08.045.
   PubMed Web of Science ®Google Scholar
• G.R. Bickerton, G.V. Paolini, J. Besnard, S. Muresan, and A.L. Hopkins, Quantifying the chemical beauty of drugs, Nat. Chem. 4 (2012), pp. 90–98. doi:10.1038/nchem.1243.
   PubMed Web of Science ®Google Scholar
• P. Ertl and A. Schuffenhauer, Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions, J. Cheminf. 1 (2009), pp. 8. doi:10.1186/1758-2946-1-8.
   PubMed Web of Science ®Google Scholar
• F. Lovering, J. Bikker, and C. Humblet, Escape from flatland: Increasing saturation as an approach to improving clinical success, J. Med. Chem. 52 (2009), pp. 6752–6756. doi:10.1021/jm901241e.
   PubMed Web of Science ®Google Scholar
• Y.A. Ivanenkov, B.A. Zagribelnyy, and V.A. Aladinskiy, Are we opening the door to a new era of medicinal chemistry or being collapsed to a chemical singularity? J. Med. Chem. 62 (2019), pp. 10026–10043. doi:10.1021/acs.jmedchem.9b00004.
   PubMed Web of Science ®Google Scholar
• P. Ertl, S. Roggo, and A. Schuffenhauer, Natural product-likeness score and its application for prioritization of compound libraries, J. Chem. Inf. Model. 48 (2008), pp. 68–74. doi:10.1021/ci700286x.
   PubMed Web of Science ®Google Scholar
• M.L. Amin, P-glycoprotein inhibition for optimal drug delivery, Drug Target Insights 7 (2013), pp. 27–34. doi:10.4137/DTI.S12519.
   PubMedGoogle Scholar
• P. Breedveld, J.H. Beijnen, and J.H.M. Schellens, Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs, Trends Pharmacol. Sci. 27 (2006), pp. 17–24. doi:10.1016/j.tips.2005.11.009.
   PubMed Web of Science ®Google Scholar
• N.A. Colabufo, F. Berardi, M. Cantore, M. Contino, C. Inglese, M. Niso, and R. Perrone, Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: Pharmaceutical, biological, and diagnostic potentials, J. Med. Chem. 53 (2010), pp. 1883–1897. doi:10.1021/jm900743c.
   PubMed Web of Science ®Google Scholar
• D. Paris, G. Ait-Ghezala, C. Bachmeier, G. Laco, D. Beaulieu-Abdelahad, Y. Lin, C. Jin, F. Crawford, and M. Mullan, The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation, J. Biol. Chem. 289 (2014), pp. 33927–33944. doi:10.1074/jbc.M114.608091.
   PubMed Web of Science ®Google Scholar
• J.E. Schweig, H. Yao, K. Coppola, C. Jin, F. Crawford, M. Mullan, and D. Paris, Spleen tyrosine kinase (SYK) blocks autophagic tau degradation in vitro and in vivo, J. Biol. Chem. 294 (2019), pp. 13378–13395. doi:10.1074/jbc.RA119.008033.
   PubMed Web of Science ®Google Scholar
• E. Tanaka, Clinically important pharmacokinetic drug-drug interactions: Role of cytochrome P450 enzymes, J. Clin. Pharm. Ther. 23 (1998), pp. 403–416. doi:10.1046/j.1365-2710.1998.00086.x.
   PubMed Web of Science ®Google Scholar
• M.C. Sanguinetti and M. Tristani-Firouzi, hERG potassium channels and cardiac arrhythmia, Nature 440 (2006), pp. 463–469. doi:10.1038/nature04710.
   PubMed Web of Science ®Google Scholar
• J.I. Vandenberg, M.D. Perry, M.J. Perrin, S.A. Mann, Y. Ke, and A.P. Hill, HERG K + channels: Structure, function, and clinical significance, Physiol. Rev. 92 (2012), pp. 1393–1478. doi:10.1152/physrev.00036.2011.
   PubMed Web of Science ®Google Scholar
• A. Metz, C. Pfleger, H. Kopitz, S. Pfeiffer-Marek, K.-H. Baringhaus, and H. Gohlke, Hot spots and transient pockets: Predicting the determinants of small-molecule binding to a protein–protein interface, J. Chem. Inf. Model. 52 (2012), pp. 120–133. doi:10.1021/ci200322s.
   PubMed Web of Science ®Google Scholar
• T. Xie, J. Yu, W. Fu, Z. Wang, L. Xu, S. Chang, E. Wang, F. Zhu, S. Zeng, Y. Kang, and T. Hou, Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: A molecular simulation study, Phys. Chem. Chem. Phys. 21 (2019), pp. 12931–12947. doi:10.1039/C9CP02024A.
   PubMed Web of Science ®Google Scholar
• V. Kumar, S. Parate, Danishuddin, A. Zeb, P. Singh, G. Lee, T.S. Jung, K.W. Lee, and M.W. Ha, 3D-QSAR-based pharmacophore modeling, virtual screening, and molecular dynamics simulations for the identification of spleen tyrosine kinase inhibitors, Front. Cell. Infect. Microbiol. 12 (2022), pp. 909111. doi:10.3389/fcimb.2022.909111.
   PubMed Web of Science ®Google Scholar
• J.A. Endicott, M.E.M. Noble, and L.N. Johnson, The structural basis for control of eukaryotic protein kinases, Annu. Rev. Biochem. 81 (2012), pp. 587–613. doi:10.1146/annurev-biochem-052410-090317.
   PubMed Web of Science ®Google Scholar
• M.F. Sk and P. Kar, Finding inhibitors and deciphering inhibitor-induced conformational plasticity in the janus kinase via multiscale simulations, SAR QSAR Environ. Res. 33 (2022), pp. 833–859. doi:10.1080/1062936X.2022.2145352.
   PubMedGoogle Scholar
• M.F. Sk, S. Haridev, R. Roy, and P. Kar, Investigating potency of TMC-126 against wild-type and mutant variants of HIV-1 protease: A molecular dynamics and free energy study, SAR QSAR Environ. Res. 32 (2021), pp. 941–962. doi:10.1080/1062936X.2021.1999318.
   PubMed Web of Science ®Google Scholar
• N.A. Jonniya, M.F. Sk, R. Roy, and P. Kar, Discovery of potential competitive inhibitors against with-no-lysine kinase 1 for treating hypertension by virtual screening, inverse pharmacophore-based lead optimization, and molecular dynamics simulations, SAR QSAR Environ. Res. 33 (2022), pp. 63–87. doi:10.1080/1062936X.2021.2023218.
   PubMed Web of Science ®Google Scholar